Closed · W81XWH-09-LCRP-LCBRNA · CFDA 12.420 · Discretionary

FY09 DOD Lung Cancer Biospecimen Resource Network Award

Federal grant opportunity posted by Defense Health Agency Contracting Activity - DHACA, cataloged on Grants.gov.

Varies
Award range
Closed
Status
January 6, 2010
Close date
1
Expected awards

The verdict

FY09 DOD Lung Cancer Biospecimen Resource Network Award is a closed discretionary listing from Defense Health Agency Contracting Activity - DHACA that offered Varies by applicant across 1 expected award. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 1,795 other opportunities from Defense Health Agency Contracting Activity - DHACA.

Varies
award range
Closed
application status
1
expected award
12.420
CFDA program

Archived opportunity record

FY09 DOD Lung Cancer Biospecimen Resource Net… is closed (last close January 6, 2010). Check the agency catalog for replacement NOFOs. Defense Health Agency Contracting Activity - DHACA still indexes 1,795 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed January 6, 2010

Posted Sep 11 Closes Jan 6

Est. Total Funding

$3,800,000

Expected Awards

1

Instrument

Grant

Description

The LCRP Lung Cancer Biospecimen Resource Network (LCBRN) Award is intended to provide infrastructure support for the development of a lung cancer biospecimen resource that will facilitate the collection, processing, annotation, storage, and distribution of high-quality human lung cancer biospecimens through a collaborative network across multiple institutions. The LCBRN will consist of a Coordinating Center that will also function as a biospecimen resource site and a minimum of two additional Biospecimen Resource Sites that will be jointly responsible for developing the biospecimen resource network for lung cancer research. The Coordinating Center and Biospecimen Resource Sites must submit a single application. It is expected that the Coordinating Center will provide unique resources that may not necessarily be available at each Biospecimen Resource Site and can be leveraged for the LCBRN as a group. The types of lung cancer biospecimens for this proposal may be quite diverse. A list of possible biospecimens may include but are not limited to tumor tissue, matching uninvolved lung parenchyma or airway epithelium, lung exhalant, tissue, blood, sputum, hair, toenails, and bronchoscopic brushings and biopsies. Additional requirements for the LCBRN will be the ability to collect, store, and manage data derived from these biospecimens. LCBRN applicants should possess the ability to derivatize DNA, RNA, and proteins, and also utilize both standard and state-of-the-art technologies (e.g., laser capture microdissection, tissue microarrays) to provide the necessary biospecimen processing for lung cancer research studies. The proposed LCBRN must collect, process, annotate, store, and distribute human lung cancer biospecimens that support two or more of the Areas of Emphasis listed below: • Identification or development of non-invasive or minimally invasive tools to improve the detection of the initial stages of lung cancer. • Identification and development of tools for screening or early detection of lung cancer. Screening may include, but is not limited to, computed tomography scans, X-rays, other imaging, biomarkers, genetics/genomics/proteomics, and assessment of risk factors. • Understanding the molecular mechanisms that lead to clinically significant lung cancer. • Identification of the mechanisms that lead to the development of the various types of lung cancer. • Identification of innovative strategies for prevention and treatment of early lung cancer. • Understanding predictive and prognostic markers to identify responders and non-responders. • Understanding acquired resistance to treatment. See the Program Announcement for the full Funding Opportunity Description.

Catch-all / unrestricted eligibility mark · W81XWH-09-LCRP-LCBRNA

Grants.gov marks FY09 DOD Lung Cancer Biospecimen Resource Net… with a catch-all / unrestricted eligibility code (Unrestricted / see official listing). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Grant. Funding-activity code maps to Science and Technology / R&D (ST). This eligibility-code string dominates the Defense Health Agency Contracting Activity - DHACA book (1,791 peers, 100% of 1,796).

Code 99
Unrestricted / see official listing

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil eReceipt HELP: 301-682-5507; help@cdmrp.org

What to do next

FY09 DOD Lung Cancer Biospecimen Resource Net… is closed; use the parent program and agency catalog for the next funding cycle.

  • Browse open federal opportunities in the same category when this listing is closed. Open opportunities
  • Look up CFDA 12.420 across all indexed listings before you commit to this opportunity alone. Eligibility finder
  • Compare award ranges across federal categories before you pick a single CFDA. All categories

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants